Cite
1298Associations of DMT therapies with COVID-19 severity in multiple sclerosis
MLA
Lotte Geyes, et al. “1298Associations of DMT Therapies with COVID-19 Severity in Multiple Sclerosis.” International Journal of Epidemiology, vol. 50, Sept. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........ec6c0ecd24b8515b27b91736b9e19442&authtype=sso&custid=ns315887.
APA
Lotte Geyes, Nikola Lazovski, Ingrid van der Mei, Ricardo Alonso, Anna Glaser, Tomas Kalincik, Tina Parciak, Rumen Ivanov, Richard Nicholas, Arnfin Bergmann, Gilles Edan, Ashkan Pirmani, Hollie Schmidt, Amber Salter, Robert J. Fox, Steve Simpson-Yap, Johana Bauer, Jan Hillert, Liesbet Peeters, … Stefan Braune. (2021). 1298Associations of DMT therapies with COVID-19 severity in multiple sclerosis. International Journal of Epidemiology, 50.
Chicago
Lotte Geyes, Nikola Lazovski, Ingrid van der Mei, Ricardo Alonso, Anna Glaser, Tomas Kalincik, Tina Parciak, et al. 2021. “1298Associations of DMT Therapies with COVID-19 Severity in Multiple Sclerosis.” International Journal of Epidemiology 50 (September). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........ec6c0ecd24b8515b27b91736b9e19442&authtype=sso&custid=ns315887.